Effect of Xanthium Strumarium on HIV-1 5′-LTR Transcriptional Activity and Viral Reactivation in Latently Infected Cells

Chinese herbal medicines (CHMs) are widely used in Asian countries. They show multiple pharmacological activities, including antiviral activities. The 5 '-long terminal repeat (LTR) region of HIV-1, required for viral transcription, is a potential drug target for HIV-1 reactivation and intrinsic cell death induction of infected or latently infected cells. Modulation of HIV-1 reactivation requires interactions between host cell proteins and viral 5 '-LTR elements. By evaluation of two CHMs- Xanthium strumarium and Pueraria montana, we found that 1) X. strumarium reactivated HIV-1 latently infected cells in J-Lat 8.4, J-Lat 9.2, U1, and ACH-2 cells in vitro; 2) 27 nuclear regulatory proteins were associated with HIV-1 5 '-LTR using deoxyribonucleic acid affinity pull-down and LC-MS/MS analyses; and 3) among them, silencing of XRCC6 reactivated HIV-1 5 '-LTR transcriptional activity. We found that X. strumarium inhibits the 5 '-LTR associated XRCC6 nuclear regulatory proteins, increases its viral 5 '-LTR promoter transcriptional activity, and reactivates HIV-1 latently infected cells in vitro. These findings may contribute to understanding the 5 '-LTR activity and the host cell nuclear regulatory protein machinery for reactivating HIV-1 and for future investigations to eradicate and cure HIV-1 infection.

Automated summary

The study evaluated the effects of Xanthium strumarium and Pueraria montana on HIV-1 reactivation and found that X. strumarium could reactivate latently infected cells while inhibiting the nuclear regulatory protein XRCC6 associated with 5'-LTR, enhancing viral promoter activity. These findings contribute to the understanding of the 5'-LTR activity and host cell nuclear regulatory protein machinery for reactivating HIV-1.